Metabolic signature of extracellular vesicles depends on the cell culture conditions.
Mari PalviainenHeikki SaariOlli KärkkäinenJenna PekkinenSeppo AuriolaMarjo YliperttulaMaija PuhkaKati HanhinevaPia R-M SiljanderPublished in: Journal of extracellular vesicles (2019)
One of the greatest bottlenecks in extracellular vesicle (EV) research is the production of sufficient material in a consistent and effective way using in vitro cell models. Although the production of EVs in bioreactors maximizes EV yield in comparison to conventional cell cultures, the impact of their cell growth conditions on EVs has not yet been established. In this study, we grew two prostate cancer cell lines, PC-3 and VCaP, in conventional cell culture dishes and in two-chamber bioreactors to elucidate how the growth environment affects the EV characteristics. Specifically, we wanted to investigate the growth condition-dependent differences by non-targeted metabolite profiling using liquid chromatography-mass spectrometry (LC-MS) analysis. EVs were also characterized by their morphology, size distribution, and EV protein marker expression, and the EV yields were quantified by NTA. The use of bioreactor increased the EV yield >100 times compared to the conventional cell culture system. Regarding morphology, size distribution and surface markers, only minor differences were observed between the bioreactor-derived EVs (BR-EVs) and the EVs obtained from cells grown in conventional cell cultures (C-EVs). In contrast, metabolomic analysis revealed statistically significant differences in both polar and non-polar metabolites when the BR-EVs were compared to the C-EVs. The results show that the growth conditions markedly affected the EV metabolite profiles and that metabolomics was a sensitive tool to study molecular differences of EVs. We conclude that the cell culture conditions of EV production should be standardized and carefully detailed in publications and care should be taken when EVs from different production platforms are compared with each other for systemic effects.
Keyphrases
- mass spectrometry
- single cell
- prostate cancer
- liquid chromatography
- wastewater treatment
- cell therapy
- magnetic resonance
- stem cells
- poor prognosis
- palliative care
- induced apoptosis
- ms ms
- cell proliferation
- binding protein
- simultaneous determination
- mesenchymal stem cells
- high resolution
- bone marrow
- signaling pathway
- quality improvement